Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Belli

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Virology|April 7, 1999
Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigenL Sernicola, F Corrias, M L Koanga-Mogtomo, et al.
Journal of Medical Primatology|September 14, 2001
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeysD R Negri, S Baroncelli, Z Michelini, et al.
The Journal of General Virology|February 12, 1998
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeysF Titti, L Sernicola, A Geraci, et al.
Journal of Preventive Medicine and Hygiene|February 1, 2013
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjectsH Czajka, S Unal, S Ulusoy, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Behavioural and Cognitive Psychotherapy|January 24, 2024
Virtually delivered guided self-help for binge eating disorder and bulimia nervosa: findings from a service evaluationBethan Dalton, Molly R Davies, Michaela Flynn, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Scientific Reports|September 9, 2023
Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017-2019 multicenter cross-sectional studyMaria Teresa Maggiorella, L Sernicola, O Picconi, et al.
The Lancet. Psychiatry|September 26, 2015
Mental health research priorities for EuropeTil Wykes, Josep Maria Haro, Stefano R Belli, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Virology|April 7, 1999
Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigenL Sernicola, F Corrias, M L Koanga-Mogtomo, et al.
Journal of Medical Primatology|September 14, 2001
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeysD R Negri, S Baroncelli, Z Michelini, et al.
The Journal of General Virology|February 12, 1998
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeysF Titti, L Sernicola, A Geraci, et al.
Journal of Preventive Medicine and Hygiene|February 1, 2013
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjectsH Czajka, S Unal, S Ulusoy, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Behavioural and Cognitive Psychotherapy|January 24, 2024
Virtually delivered guided self-help for binge eating disorder and bulimia nervosa: findings from a service evaluationBethan Dalton, Molly R Davies, Michaela Flynn, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Scientific Reports|September 9, 2023
Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017-2019 multicenter cross-sectional studyMaria Teresa Maggiorella, L Sernicola, O Picconi, et al.
The Lancet. Psychiatry|September 26, 2015
Mental health research priorities for EuropeTil Wykes, Josep Maria Haro, Stefano R Belli, et al.
Pageof 4